International Publications Archive - Seite 103 von 223 - IOZK

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

2013-03-04/in Dendritic Cells, Hypernephroma, International Publications /von 2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates

2013-03-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401

Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity

2013-02-15/in Dendritic Cells, International Publications /von 2013-02-15 / Cancer Res. 2013 Apr;73(8):2493-504

Harnessing the immune system for the treatment of non-small-cell lung cancer

2013-02-11/in International Publications, NSCLC /von 2013-02-11 / J. Clin. Oncol. 2013 Mar;31(8):1021-8

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / J. Immunother. 2013 Feb;36(2):152-7

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

2013-02-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2013-02-01 / BioDrugs 2013 Feb;27(1):35-53

Current status of immunotherapy for the treatment of biliary tract cancer

2013-02-01/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-72

Vaccine strategies for glioblastoma: progress and future directions

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / Immunotherapy 2013 Feb;5(2):155-67

Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy

2013-01-23/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2013-01-23 / J. Virol. 2013 Apr;87(7):3792-800

Oncolytic virus therapy for cancer: the first wave of translational clinical trials

2013-01-10/in International Publications, Newcastle Disease Virus /von 2013-01-10 / Transl Res 2013 Apr;161(4):355-64